Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity

Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity

Influenza A and B viruses are a global threat to human health and increasing resistance to the existing antiviral drugs necessitates new concepts to expand the therapeutic options. Glycopeptide derivatives have emerged as a promising new class of antiviral agents. To avoid potential antibiotic resis...

Full description

Bibliographic Details
Main Authors: Zsolt Szűcs, Lieve Naesens, Annelies Stevaert, Eszter Ostorházi, Gyula Batta, Pál Herczegh, Anikó Borbás
Format: Article
Language:English
Published: MDPI AG 2020-06-01
Series:Pharmaceuticals
Subjects:
glycopeptide antibiotic
vancomycin aglycone hexapeptide
antiviral
influenza virus
human coronavirus
Online Access:https://www.mdpi.com/1424-8247/13/7/139

Internet

https://www.mdpi.com/1424-8247/13/7/139

Similar Items